Is Culprit-Lesion-Only PCI in Cardiogenic Shock Still Better at 1 Year?
Authors:
- 1 November 2018
- journal article
- editorial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 379 (18) , 1775-1776
Abstract
Cardiogenic shock occurs in approximately 5% of patients with an acute coronary syndrome — usually, but not always, after ST-segment elevation myocardial infarction. If a large amount of myocardial tissue has become ischemic or injured, pump failure and reduced blood flow to vital organs occur. Urgent percutaneous coronary intervention (PCI) of the culprit lesion is currently the only therapy associated with a significant decrease in mortality.1 No other intervention with a device or pharmacologic agent has shown a significant benefit, and as a consequence, mortality has plateaued at 50% in recent years. On angiography performed during the acute phase, clinically . . .Keywords
This publication has 9 references indexed in Scilit:
- One-Year Outcomes after PCI Strategies in Cardiogenic ShockNew England Journal of Medicine, 2018
- 2018 ESC/EACTS Guidelines on myocardial revascularizationEuropean Heart Journal, 2018
- Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability: results from the German prospective, multicentre FITT-STEMI trialEuropean Heart Journal, 2018
- PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic ShockNew England Journal of Medicine, 2017
- Management of refractory cardiogenic shockNature Reviews Cardiology, 2016
- Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic ShockNew England Journal of Medicine, 2012
- Correlates of one-year survival inpatients with cardiogenic shock complicating acute myocardial infarctionJACC, 2003
- Early Revascularization in Acute Myocardial Infarction Complicated by Cardiogenic ShockNew England Journal of Medicine, 1999
- DISCREPANCIES BETWEEN THE EFFECTS OF CORONARY REPERFUSION ON SURVIVAL AND LEFT VENTRICULAR FUNCTIONThe Lancet, 1989